Nicardipine & Labetalol Effects on Cerebral Hemodynamics in Preeclampsia

See also
Status	Clinical Trial	Phase
Terminated	`NCT04243278` - Postpartum Low-Dose Aspirin After Preeclampsia for Optimization of Cardiovascular Risk (PAPVASC)	Early Phase 1
Not yet recruiting	`NCT03318211` - Discontinuation of Magnesium Sulfate After Delivery in Women With Severe Preeclampsia. A Randomized Controlled Trial	Phase 4
Completed	`NCT05594056` - Transorbital Ultrasound of Optic Nerve Sheath Diameter Between Healthy Pregnant Women and Those With Severe Preeclampsia.	N/A
Not yet recruiting	`NCT06373367` - Preeclampsia Educational Program Study (PrEPS)	N/A
Not yet recruiting	`NCT04855513` - Prevention of Pre-eclampsia Using Metformin: a Randomized Control Trial	N/A
Not yet recruiting	`NCT05232994` - Metformin and Esomeprazole For Preterm Pre-eclampsia	Phase 1
Completed	`NCT04392375` - Nifedipine XL Versus Placebo for the Treatment of Preeclampsia With Severe Features During Induction of Labor	Phase 4
Recruiting	`NCT03978767` - Preeclampsia And Nonsteroidal Drugs for Analgesia: a Randomized Non Inferiority Trial	Phase 2
Completed	`NCT04236258` - Comparing Nifedipine and Enalapril in Medical Resources Used in the Postpartum Period	Phase 4
Completed	`NCT04756661` - Uterotonics for Severe Preeclampsia	N/A
Active, not recruiting	`NCT04660032` - Nudge to Drive Transitions of Care	N/A
Completed	`NCT04103489` - The Use of Eculizumab in HELLP Syndrome	Phase 1
Enrolling by invitation	`NCT04794855` - Risk Prediction Model of Preeclampsia
Recruiting	`NCT04311749` - Expanded NIPT for Pregnancy Complications
Active, not recruiting	`NCT06359015` - Metformin and Esomeprazole in Preterm Pre-eclampsia	Phase 4
Recruiting	`NCT05610774` - Optic Nerve Sheath Diameter in Pre-Eclamptic Parturient Receiving Magnesium Sulfate Combined With Dexmedetomidine	N/A
Completed	`NCT03815110` - Preeclampsia Risk Assessment: Evaluation of Cut-offs to Improve Stratification
Completed	`NCT03210350` - Effect of Magnesium Sulphate on the Intracranial Pressure of Preeclamptic Patients
Completed	`NCT03451266` - Effects of Vitamin C Administration on Extravascular Lung Water in Patients With Severe Features of Preeclampsia	Phase 1
Active, not recruiting	`NCT06360601` - Intravenous Labetalol Versus Hydralazine in Preeclampsia	Phase 1/Phase 2

NCT number	NCT03761888
Study type	Observational [Patient Registry]
Source	Hopital Antoine Beclere
Contact	Mickaël SOUED
Phone	+33145374273
Email	mickael.soued@aphp.fr
Status	Recruiting
Phase
Start date	November 29, 2018
Completion date	May 2019

Nicardipine and Labetalol Effects on Cerebral Hemodynamics in Preeclampsia — PREMODYM

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms